Idiotype protein of membrane immunoglobulin on malignant B cell (Idiotype (Id))

The idiotype protein on malignant B cells is the unique antigenic structure formed by the variable regions of the surface immunoglobulin (antibody) present on a B-cell lymphoma or leukemia clone[1][3][4]. Each malignant clone expresses a distinctive idiotype resulting from somatic gene rearrangement and mutation, making it a specific marker and therapeutic target[2][3][4]. This protein enables the precise targeting of B-cell tumors with anti-idiotype antibodies, idiotype-based vaccines, or engineered immunotoxins, offering significant potential for personalized immunotherapy. However, generating therapies requires individualized design for each patient, and tumor escape via idiotype mutation remains a clinical challenge[4].

Other names

IdiotypeTumor-specific idiotypeB-cell receptor idiotypeSurface immunoglobulin idiotypeId protein

Antibody-mediated cytotoxicity (anti-idiotype antibodies bind and induce killing of malignant B cells); Antibody-drug conjugate delivery (direct cytotoxic payload to B-cells, resulting in apoptosis); Vaccine-induced immune response (idiotype vaccination primes the adaptive immune system to target B lymphoma cells expressing the idiotype)